Govt won’t lose money on China-made rapid antibody testing kits

plasma therapy for COVID-19

New Delhi, April 28: The Indian Council of Medical Research (ICMR) has claimed that the Indian government won’t lose any money on the procurement of ‘overpriced’ China-made rapid antibody testing kits via distributors.

Moreover, Director Shekhar Mande said that trial of Mycobacterium w (Mw) has started.
Speaking to ANI, Mande said: “There is one particular formulation which is called Mycobacterium w (Mw). It is a heat-killed bacteria that we are trying on different patients. We have taken approval of the Drug Controller General of India (DCGI) and that trial has started.”
He said that they are also trying phytopharmaceuticals and approaching the Drug Controller General of India for the approval.
“We are also trying phytopharmaceuticals, some extracts from plants for which also we are approaching the DCGI for approval,” he said.

Total
4
Shares
Related Posts